Found 389 matching trials
Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma PHASE2 This study is to evaluate the efficacy of risk-adapted treatment strategy f...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant PHASE2 This is a Phase II pilot study to determine the efficacy of three fixed dos...
Show More Status
Enrolling By Invitation
Location
Phoenix Children's Hospital
Learn More & Join Trial
A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) PHASE2 This study has 2 parts.
The main aim of Part 1 is to check for side effect...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo N/A The cohort included only major patients with non-segmental vitiligo and no ...
Show More Learn More & Join Trial
DC/NK Cell Therapy PHASE2 Primary Outcomes The primary objective of this trial is to test the safety ...
Show More Location
National Taiwan University Hospital Yunlin Branch
Learn More & Join Trial
Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia PHASE1 The purpose of this study is to evaluate safety, feasibility and maximum to...
Show More Location
Centro Terapia e Tecnologia Celular
Learn More & Join Trial
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 PHASE1 This study is a Phase 1 / 2 trial to determine the safety and efficacy of C...
Show More Learn More & Join Trial
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma PHASE1 This phase I trial studies the side effects and best dose of vorinostat whe...
Show More Status
Active Not Recruiting
Location
Johns Hopkins University/Sidney Kimmel Cancer Center
Learn More & Join Trial
Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy PHASE2 In this study, participants with high-risk hematologic malignancies undergo...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab PHASE1 Gastrointestinal (GI) cancers account for the most common cancers. Despite ...
Show More Location
University hospital of Besançon
Learn More & Join Trial